Objective: To investigate structural and functional alterations of gray matter (GM) and examine their clinical relevance in neuromyelitis optica (NMO) using multimodal magnetic resonance imaging (MRI) techniques. Methods: A total of 35 NMO and 36 healthy controls (HC) were recruited in this study. Cortical lesions were investigated by double inversion recovery technique. Five voxel-wise MRI measurements were obtained for each participant in the GM including gray matter volume (GMV), fractional anisotropy (FA), mean diffusivity (MD), amplitude of low-frequency fluctuation (ALFF), and weighted functional connectivity strength (wFCS). Between-group differences, cross-modality relationships, and MRI-clinical correlations were examined. Results: No cortical lesions were found in NMO. Compared to HC, NMO patients exhibited significantly decreased GMV in deep GM and cortical regions involving visual function and cognition. Diffusion GM abnormalities were widespread in the patients. Decreased ALFF and wFCS were observed in the patients in sensorimotor, visual, cognition, and cerebellar sites. GM structural alterations were correlated with cognitive but not physical disability scores of the patients. Conclusion: Despite the lack of focal cortical lesions, patients with NMO exhibit both structural and functional alterations of GM in cerebrum and cerebellum that predominantly involve deep GM, visual, motor, and cognitive regions. GM alterations are associated with cognitive impairment but not physical disability.
Introduction
Neuromyelitis optica (NMO) (Devic's disease) is an astrocytopathy and demyelinating disease of central nervous system, typically without brain lesions on conventional magnetic resonance images, especially in early disease. 1, 2 However, recent neuroimaging studies consistently identify magnetic resonance imaging (MRI) abnormalities in NMO such as periependymal lesions surrounding the ventricular system, white matter (WM) lesions, and lesions involving corticospinal tracts. 3 Moreover, advanced MRI techniques have demonstrated cerebral abnormalities, [4] [5] [6] [7] especially gray matter (GM) alterations, [8] [9] [10] [11] which may be the neural basis of cognitive impairments in NMO.
In NMO, cortical lesions were reported to be absent using double inversion recovery (DIR) sequence. 8 However, using structural and diffusion MRI, both GM atrophy 9, 12 and microstructural abnormalities 13, 14 were separately identified. Moreover, functional MRI studies revealed GM abnormalities in both taskevolved 15 and spontaneous brain activity. 6, 16 These studies advance our understanding of GM pathology in NMO; however, most of the above findings are from a single modality with differences in samples, clinical features, and grouping criteria. Relative to a single modality, recent studies have highlighted the importance of multimodal integration in revealing neural substrate underlying various brain disorders. 17, 18 In NMO, there are two prior multimodal studies. One investigated structural alterations in a small sample (n = 8) 19 and the other focused on the thalamus. 20 In this study, we systematically investigated structural and functional alterations of GM in NMO by combining DIR, high-resolution structural MRI, diffusion MRI, and resting-state functional MRI (rs-fMRI). Furthermore, we examined the similarities and differences among different MRI modalities in the locations of NMO-related abnormalities. Finally, clinical correlates of GM structural and functional alterations were examined.
Materials and methods

Participants
This study was approved by institutional review board of Xuanwu Hospital, Capital Medical University, and written informed consent was obtained from each participant. A total of 40 NMO patients were enrolled in this study from January 2012 to December 2013. NMO diagnosis was made according to the 2006 diagnostic criteria. 2 The demographic information and clinical characteristics including Expanded Disability Status Scale (EDSS), 21 disease duration, number of relapses, Mini-Mental State Examination (MMSE), 2-second Paced Auditory Serial Addition Test (PASAT 2) and 3-second PASAT (PASAT 3) were recorded for all the patients. All the patients' clinical attacks were restricted to spinal cord and optic neuritis. All the patients were relapsing NMO and 27 patients (27/40, 67.5%) were aquaporin-4 (AQP4) antibody positive measured by an indirect immunofluorescence method. 22 All the patients received steroid treatment, and seven patients received additional immunosuppressant therapy. We enrolled 37 gender-, age-, and education-matched healthy controls (HC) with no previous history of neurological or psychiatric dysfunction and with normal findings on neurological and MRI examination. Of note, data set from a subset of the general population has been used to study the thalamus in patients with NMO. 20 
Image acquisition
All the multimodal MRI scans including conventional MR sequences (T2 and fluid-attenuated inversion recovery (FLAIR)), DIR, high-resolution T1-weighted imaging, diffusion tensor imaging (DTI), rs-fMRI were performed on a 3.0-Tesla MR system (Siemens Magnetom Trio Tim System, Siemens Healthcare GmbH, Erlangen, Germany). The MRI scans of the NMO patients were acquired at least 2 weeks from the last relapse and treatment to minimize their confounding effects on subsequent multimodal brain measurements. The median time from the last relapse of the patients is 7 months with a range from 2 to 11 months (see Supplementary appendix e-1 for detailed multimodal MRI parameters).
Multimodal image analysis
Based on the multimodal MRI data acquired above, we analyzed WM lesion from T2-weighted and FLAIR images, GM lesion from DIR images, GM volume (GMV) from T1 images, microstructural integrity (fractional anisotropy (FA) and mean diffusivity (MD)) from diffusion images, and intrinsic functional architecture including amplitude of low-frequency fluctuation (ALFF) (local oscillation power) 23 and weighted functional connectivity strength (wFCS) (interregional functional connectivity over the whole brain) 24 from rs-fMRI images (for details of multimodal imaging preprocessing and measure calculation, see Supplementary appendix e-1).
Statistical analysis
Discrete gender data were analyzed using a chi-square test. For other demographic and clinical continuous variables, two-sided two-sample t test or Wilcoxon rank sum tests were used to assess between-group differences depending on whether they were normally distributed (Lilliefors test). For the multimodal MRI measures, a voxel-wise general linear model was used to infer between-group differences. To correct for the multiple comparisons, a height threshold of p < 0.001 combined with an extent threshold of p < 0.05 were employed, which corresponded to a corrected p < 0.05 as determined by the Monte Carlo simulations. 25 Dice coefficient and partial correlation analyses were used to estimate cross-modality spatial overlap and quantitative relationships for regions showing NMO-related alterations. Partial correlation was also used to estimate clinical-MRI relationships in the patients. The effects of age and gender were controlled for all MRIrelated statistical analyses (i.e. between-group comparison and correlation analysis). Gross and subtle head motion parameters were treated as extra covariates for rs-fMRI-based analysis. Additionally, we also examined effects of clinical attacks (optic neuritis or myelitis) and WM lesions on multimodal MRI alterations in the patients (Supplementary appendix e-1).
Results
Demographic and clinical characteristics
For the current data set, two NMO patients exhibited relatively large cortical defects possibly associated with either old infarcts or trauma and thus were excluded conservatively from further analyses. In addition, three NMO patients and one HC were excluded due to image artifacts by visual inspection. All the demographic and clinical characteristics for the remaining 35 NMO patients and 36 HC are summarized in Table 1 . There were no significant differences in age, gender, and educational level between the NMO and HC groups (all p > 0.05). The patients had significant lower scores in the PASAT 2, PASAT 3, and MMSE compared with the HC (all p < 0.05). The cognitive deficits remained significant in NMO after taking educational level as a covariate.
WM and GM lesions
In all, 20 out of the 35 NMO patients had no WM lesions on cerebral MRI and 15 had non-specific WM lesions (small rounded WM hyperintensities on T2/ FLAIR, which did not fulfill the McDonald Criteria for multiple sclerosis lesions). The mean lesion volume was 5.12 (±3.86) mL for the patients. No cortical lesions were identified in the NMO patients based on DIR.
Between-group differences of morphological and microstructural organization
Compared with the HC, the NMO patients showed significantly decreased GMV in the bilateral thalamus, insula, middle temporal gyrus and anterior cingulate, the right caudate and inferior frontal gyrus, and the left calcarine (p < 0.05, corrected) ( Figure 1(a) ). For diffusion-based MD and FA, widespread brain regions in both the cerebrum and cerebellum were abnormal compared with the HC. Specifically, in addition to the regions showing decreased GMV, the patients with NMO showed significantly decreased FA in the precentral gyrus, precuneus and parahippocampal gyrus/hippocampus (all bilateral), and the left amygdala (Figure 1(b) ) and the cerebellar anterior lobe (bilateral, Figure 2(a) ). A similar but even more diffuse pattern of increased MD in the patients compared with the HC was observed. The greatest abnormalities were found in the medial prefrontal, lateral temporal cortex, and deep GM structures (Figures 1(c) and 2(b) ).
Between-group differences of functional measurements
Limited and regionally specific NMO-related alterations were found in the functional scans. Specifically, for the ALFF, significant decreases were mainly observed in sensorimotor (e.g. the bilateral paracentral lobule, the right supplementary motor area, and precentral gyrus) and visual cortex (e.g. the right inferior and middle occipital gyrus) (p < 0.05, corrected) (Figure 1(d) ), while for the wFCS, NMO-related decreases were primarily observed in visual (e.g. the superior occipital gyrus and cuneus, the right fusiform) and cognition-related areas (e.g. the bilateral middle cingulate gyrus and the left anterior cingulate gyrus) and the cerebellum (p < 0.05, corrected) (Figures 1(e) and 2(c)). Figure 3 (a) shows spatial overlaps among the five multimodal MRI-based measures in revealing NMOrelated GM alterations. The most frequently affected regions included deep GM structures (e.g. the bilateral thalamus and caudate), medial prefrontal cortex and temporal lobe locations (e.g. hippocampus/parahippocampal gyrus and superior temporal gyrus), and insula. Further pairwise cross-modality comparisons showed that the largest spatial overlap was observed between FA and MD (dice coefficient = 0.289), followed by GMV and MD (dice coefficient = 0.179) and GMV and FA (dice coefficient = 0.087). The spatial overlaps between other combinations were relatively low. Of note, there was no common region that simultaneously exhibited GMV and functional (ALFF/ wFCS) alterations in NMO (Figure 3(b) ). We further quantified pairwise cross-modality correlations in the regions (cluster size > 20 voxels) that simultaneously exhibited NMO-related alterations (Figure 3(c) ) in the patient group. Significantly positive correlations were observed between GMV and FA (r = 0.481, p = 0.005, mean across clusters) and between FA and wFCS (r = 0.398, p = 0.022, mean across clusters), and significantly negative correlations were observed between GMV and MD (r = −0.491, p = 0.004, mean across clusters) and between FA and MD (r = −0.548, p < 0.001, mean across clusters) (Figure 3(d) ).
Cross-modality relationship
MRI-clinical relationship
For the NMO patients, significant correlations were observed between structural brain measures (GMV, FA, and MD) and clinical characteristics (p < 0.05, false discovery rate corrected) in multiple GM structures. In detail, the PASAT 2 was correlated with GMV in the left thalamus, FA in the brainstem and MD in the right thalamus, the PASAT 3 was associated with MD in the right parahippocampus and superior temporal gyrus, the disease duration was correlated with FA and MD in the left parahippocampus/hippocampus, and the number of relapses was related to MD in the bilateral cuneus. The scatter plots of all these correlations are shown in Figure 4 . No significant correlations were observed between the EDSS (including cerebellar functional system score) and the multimodal MRI measurements in the patients. There were also no significant effects of clinical attacks (optic neuritis or myelitis) and WM lesions on the multimodal MRI measurements in the patients (p > 0.05, false discovery rate corrected).
Discussion
In this study, we examined GM structural and functional alterations in NMO by employing multimodal quantitative MRI techniques. The main findings can be summarized as follows: (1) no focal cortical lesions were found in NMO patients; (2) both structural and functional alterations in GM were identified in NMO, with structural abnormalities being much more extensive than functional changes, and predominantly affected areas included deep GM nuclei and cortical regions involved in vision, motor function, and cognition; (3) multimodal MRI provided complementary information by capturing NMO-induced GM alterations, with DTI revealing much more widespread abnormalities than other structural and functional MRI measures; and (4) structural GM alterations, particularly microstructural abnormalities, were correlated with the patients' cognitive impairment, but not physical disability.
Nearly half of the included NMO patients showed non-specific WM lesions, while none exhibited cortical lesions in this study. These findings are consistent with previous findings 5, 8, 26 and confirm that non-specific WM lesions (not fulfill the criteria for multiple sclerosis lesions), and the absence of cortical lesions is an MRI feature of NMO distinguishing them from multiple sclerosis. 10 Structural and functional alterations were observed in GM in NMO. Specifically, the voxel-based morphometry analysis revealed regional GM atrophy in multiple regions. This is consistent with previous studies reporting GM atrophy in NMO in terms of either GMV [10] [11] [12] or cortical thickness. 8, 9 Specifically, NMO-related GM atrophy principally occurred in deep GM nuclei and several cortical areas related to vision, sensorimotor, and cognition such as anterior cingulate cortex. This atrophy could be caused by primary cortical pathology such as an inflammatorydegenerative process induced by AQP4 or secondary trans-synaptic degeneration triggered by axonal loss in lesions in the optic nerve and spinal cord.
Microstructural abnormalities have been previously reported to be widespread in WM fibers. 4, 27 Using a diffusivity histogram 13 or region of interest (ROI) analysis, 14 significant diffusion changes have also been observed in the normal-appearing GM in NMO. Our study extends previous findings using a voxelbased whole-brain method showing that diffusion changes are widely distributed in brain areas implicated in visual, sensorimotor, and cognitive functions. Given that a serum immunoglobulin G autoantibody (NMO-IgG) selectively binds to AQP4 28 in NMO, we speculate that the disruption of water homeostasis may be one key pathophysiological basis for the observed diffusion changes. As a novel finding, diffusion abnormalities were also found in the cerebellum, possible factors contributing to cerebellar diffusion abnormalities in NMO include primary pathogenic effect of the anti-AQP4 antibody since AQP4 is highly expressed in cerebellum, 29 and secondary degeneration since the cerebellum has direct and dense connections to the spinal cord. 30 To examine functional architecture, we employed ALFF and wFCS to study local activity fluctuations and interregional connectivity in NMO, respectively. Our results showed subtle functional alterations (both for local neural activity (ALFF) and for functional coupling (wFCS)), mainly in motor, vision, and cognition-related areas, corresponding to the symptoms in NMO, and consistent with previous findings. 6, 11 Interestingly, the cerebellum also showed decreased wFCS in NMO, proposing the cerebellum as a possible NMO-related disconnection site. Further studies are needed to confirm our newly described cerebellar MRI abnormalities. We observed that most of the brain areas with decreased GMV in NMO were those also harboring diffusion changes, and significant associations were observed between regional FA/MD and GMV in the patients. Given that no focal cortical pathology was observed on the DIR images in this study and on ultrahigh-field MR images in previous studies, 26 the observed volumetric and microstructural alterations of deep GM and cortical areas may commonly reflect trans-synaptic degeneration caused by axonal loss in the lesions. 31 However, functional MRI changes were partly limited to areas with diffusion abnormalities in the absence of morphological alterations, implying the existence of additional and independent mechanism for functional alterations in NMO. The tight microstructural-morphological and weak structuralfunctional associations of multimodal MRI changes in NMO are consistent with our previous studies in multiple sclerosis and/or NMO 20, 32 and suggest that structural and functional fusion analysis could provide unique and complementary information on these two diseases. Notably, there are few studies currently that directly compare these two diseases from a multimodal integrative perspective, which is an important topic in the future. Overall, our results indicate that NMO is associated with common and distinct GM alterations among different MRI modalities, and microstructural diffusion abnormalities may be the most sensitive measures to detect early and subtle GM damages in NMO. Future studies are needed to provide deeper insights into these findings by establishing sequential or causal relationships among NMO-related multimodal alterations with the help of computational modeling and simulation.
Significant correlations with cognitive scores of the patients were found for GM structural changes, particularly microstructural abnormalities, in several brain areas, such as thalamus and parahippocampus. 34 it is interesting in the future to examine functional brain alterations of NMO patients while performing cognitive tasks. Finally, this study mainly focused on local brain architecture in NMO. Given the highly integrative nature of the brain, 35 it will be an interesting topic in future to explore NMO-related cortical reorganization from a network perspective.
In conclusion, despite the lack of focal cortical lesions, patients with NMO exhibited both structural and functional alterations of GM in cerebrum and cerebellum that predominantly involved deep GM, visual, motor, and cognitive regions. Multimodal MRI techniques were complementary to capture NMOrelated GM abnormalities, but DTI changes were the most widespread. GM alterations, especially diffusion abnormalities, were associated with both disease duration and number of relapses and correlated with cognitive impairment but not physical disability in NMO. 
